Long term follow-up of endometriosis after two different therapies (Gestrinone and Buserelin)

Clinical and Experimental Obstetrics and Gynecology

Volumn 23, Issue 4, 1996, Pages 198-204

  Nieto, A ^a,b   Tacuri, C ^a   Serra, M ^a   Keller, J ^a   Cortes Prieto J ^a  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b NONE   (Spain)

Author keywords

Analogs of LHRH; Buserelin; Efficacy; Endometriosis; Gestrinone; Tolerance

Indexed keywords

BUSERELIN; GESTRINONE;

ACNE; ADULT; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; CONSTIPATION; DRUG EFFICACY; DRUG TOLERANCE; ENDOMETRIOSIS; FEMALE; FLUSHING; FOLLOW UP; HEADACHE; HIRSUTISM; HUMAN; INTRANASAL DRUG ADMINISTRATION; LEG EDEMA; METRORRHAGIA; NAUSEA; ORAL DRUG ADMINISTRATION; RECURRENCE RISK; SEBORRHEA; SIDE EFFECT; TIME; TREATMENT FAILURE; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; BUSERELIN; ENDOMETRIOSIS; FEMALE; FOLLOW-UP STUDIES; GESTRINONE; HUMANS; PROGESTERONE CONGENERS; PROSPECTIVE STUDIES; RECURRENCE; REMISSION INDUCTION; UTERINE DISEASES;

EID: 0030465034     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Barbieri R.L.: "Endometriosis 1990". Drugs, 1990, 39, 502-510.
2. Kauppila A., Isomaa V., Ronnberg L. et al.: "Effect of gestrinone in endometriosis tissue and endometrium". Fertil. Steril., 1985, 44, 466-470.
3. Coutinho E. M.: "Therapeutic experience with gestrinone". Prog. Clin. Biol Res., 1990, 323, 233-240.
4. Forbes K. L., Thomas F. J.: "Tissue and endocrine responses to gestrinone and danazol in the treatment of endometriosis". Reprod. Fertil. Dev., 1993, 5, 103-109.
5. Coutinho E. M.: "Treatment of endometriosis with gestrinone (R 2323), a synthetic antiestrogen, antiprogesterone". Am. J. Obstet. Gynecol., 1982, 144, 895-898.
6. Shaw R. W., Frase H. M., Boyle H.: "Intranasal treatment with luteinizing releasing hormone agonist in women with endometriosis". Br. Med. J., 1983, 287, 1667-1669.
7. Lemay A., Matheux R., Faure N. et al.: "Reversible hypogonadism induced by a luteinizing releasing hormone (LHRH) agonist (Buserelin) as a new therapeutic approach for endometriosis". Fertil. Steril., 1984, 41, 863-871.
8. Biberoglu K., Gursoy R., Yildiz A.: "Treatment of estrogen - dependent gynecological disorders with the gonadotropin releasing hormone agonist buserelin". Gynecol. Endocrinol., 1991, 5, 109-122.
9. Kiesel L., Sandow J., Bertges K. et al.: "Serum concentration and urinary excretion of the luteinizing hormone-releasing hormone agonist buserelin in patients with endometriosis". J. Clin. Endocrinol. Metab., 1989, 69, 1167-1173.
10. The American Fertility Society: "Revised American Fertility Society classification of endometriosis: 1985". Fertil. Steril., 1985, 43, 351-352.
11. Terekawa N.: "Studies on endocrine therapy of endometriosis". Nippon Sanka Fuijnka gakkai Zasshi, 1989, 41, 981-989.
12. Marchini M., Fedele L., Bianchi S. et al.: "Endometrial patterns during therapy with danazol or gestrinone for endometriosis: structural and ultrastructural study". Hum. Pathol., 1992, 23, 51-56.
13. Thomas E. J., Cooke F.D.: "Impact of gestrinone on the course of asymptomatic endometriosis". Br. Med. J., 1987, 294, 272-274.
14. Ronnberg L., Koskimies A., Laatikainen T. et al.: "Eficacia de un agonista de la hormona liberadora de gonadotropinas (Buserelina) en el tratamiento de la endometriosis". Acta Obstet. Gynecol. Scand. (edición española), 1990, 3, 201-205.
15. Fedele L., Bianchi S., Bocciolone L. et al.: "Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study". Fertil. Steril., 1993, 516-521.
16. Kiesel L., Bertges K., Von-Holst T. R. et al.: "Treatment of endometriosis". Arch. Gynecol. Obstet., 1989, 245, 937-940.
17. Kauppila A. J., Telimaa S., Ronnberg L.: "Esteroides en el tratamiento de la endometriosis". Acta Obstet. Gynecol. Scand. (edición espanõla), 1990, 3, 3-9.
18. Hess R., Cunill E., Fuchtner C. et al.: "The gestrinone (R-2323) treatment of endometriosis". Rev. Chil. Obstet. Ginecol., 1992, 57, 334-340.
19. Nieto-Díaz A., Tacuri-Cevallos C., Valenzuela-Ruiz P. et al.: "Endometriosis; Histological and clinical response to gestrinone". In: E. Coutinho and P. Spínola (Eds.), "Book of Abestracts". 4th World Congress on Endometriosis, Salvador de Bahia (Brasil), 1994, p. 24.
20. Ronnberg L., Jarvinen P.A.: "Pregnancy rates following various therapy modes for endometriosis in infertile patients". Acta Obstet. Gynecol. Scand., 1984, 23, 69-72.
21. Ruiz-Velasco V., Arceo J. R., Armesto A.: "Comparative efficacy of gestrinone and danazol in infertile women with endometriosis". Int. J. Fertil. Menopausal Stud., 1993, 38, 22-27.
22. Robyn C., Delogne-Desnoec J., Bourdoux P. et al.: "Endocrine effects of gestrinone". In: Raynaud J. P., Ojasoo T., Martini L. (Eds.), 'Medical management of endometriosis'. New York, Raven Press, 1984, 207-221.
23. Coutinho E. M.: "Gestrinona en el tratamiento de miomas". Acta Obstet. Gynecol. Scand. (edición española), 1990, 3, 33-40.
24. Schriock E., Monroe S. E., Henzl M et al.: "Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafatelin)". Fertil. Steril., 1985, 44, 583-588.
25. Waller K. G., Shaw R. W.: "Gonadotropinreleasing hormone analogues for the treatment of endometriosis: long-term follow-up". Fertil Steril., 1993, 59, 511-515.